Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01704573 · ClinicalTrials.gov registry record
Nicotinic Receptor Levels After Stopping Smoking
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 20
- Enrollment target
NCT01704573: Completed study, sponsored by University of Pennsylvania.
NCT01704573 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01704573 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This positron emission tomography (PET) study examines the effects of 24 hours abstinence from smoking on return to availability of neuronal nicotinic receptors in slow and fast metabolizers of nicotine.
Interventions
- DRUG 2-[18F]-fluro-3-[2(S)-2-azethidinylmethoxy]-pyridine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01704573
The ClinicalTrials.gov registry entry for NCT01704573 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 2-[18F]-fluro-3-[2(S)-2-azethidinylmethoxy]-pyridine is the first listed.
NCT01704573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01704573 about?
NCT01704573 is a clinical study titled "Nicotinic Receptor Levels After Stopping Smoking". This positron emission tomography (PET) study examines the effects of 24 hours abstinence from smoking on return to availability of neuronal nicotinic receptors in slow and fast metabolizers of nicotine.
What is the current status of trial NCT01704573?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2010-10. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01704573?
The interventions under investigation include: 2-[18F]-fluro-3-[2(S)-2-azethidinylmethoxy]-pyridine (DRUG).
Who is sponsoring clinical trial NCT01704573?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.